Repurposing auranofin to treat Clostridium difficile infection by targeting selenium

This research investigated the role of selenoproteins in the bacterial human pathogen Clostridium difficile and tested auranofin as a treatment for this infection. Auranofin was found to effectively kill the bacteria and reduce the cytotoxic effect of its toxins, supporting its use as a new treatment for Clostridium difficile infection.<br>